🇦🇺Australia

AEFI Under-Reporting Costs

1 verified sources

Definition

94% under-reporting by healthcare professionals delays detection of safety issues in complementary medicines, resulting in regulatory interventions, recalls, and compensation costs.

Key Findings

  • Financial Impact: 2-5% annual revenue loss from recalls and claims; 20-40 hours/month manual reporting burden
  • Frequency: Ongoing due to 94% under-reporting rate
  • Root Cause: Voluntary reporting system with barriers; lack of streamlined documentation

Why This Matters

The Pitch: Alternative Medicine players in Australia 🇦🇺 incur 2-5% revenue loss from poor quality signals and recalls due to adverse reaction reporting gaps. Automation captures all events for proactive compliance.

Affected Stakeholders

Practitioners, Clinic Managers, Pharmacovigilance Staff

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇦🇺 Be first to access this market's intelligence